- Home
- PHIO vs FTEL Comparison
PHIO vs FTEL Comparison
Compare PHIO & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- FTEL
- Stock Information
- Founded
- PHIO 2011
- FTEL 2007
- Country
- PHIO United States
- FTEL Australia
- Employees
- PHIO N/A
- FTEL N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- PHIO Health Care
- FTEL
- Exchange
- PHIO Nasdaq
- FTEL Nasdaq
- Market Cap
- PHIO 10.2M
- FTEL 9.8M
- IPO Year
- PHIO N/A
- FTEL 2023
- Fundamental
- Price
- PHIO $2.18
- FTEL $0.48
- Analyst Decision
- PHIO Strong Buy
- FTEL
- Analyst Count
- PHIO 3
- FTEL 0
- Target Price
- PHIO $10.67
- FTEL N/A
- AVG Volume (30 Days)
- PHIO 2.7M
- FTEL 565.4K
- Earning Date
- PHIO 08-14-2025
- FTEL 08-26-2025
- Dividend Yield
- PHIO N/A
- FTEL N/A
- EPS Growth
- PHIO N/A
- FTEL N/A
- EPS
- PHIO N/A
- FTEL N/A
- Revenue
- PHIO N/A
- FTEL $4,990,695.00
- Revenue This Year
- PHIO N/A
- FTEL N/A
- Revenue Next Year
- PHIO N/A
- FTEL N/A
- P/E Ratio
- PHIO N/A
- FTEL N/A
- Revenue Growth
- PHIO N/A
- FTEL 29.02
- 52 Week Low
- PHIO $0.97
- FTEL $0.36
- 52 Week High
- PHIO $9.79
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- PHIO 40.77
- FTEL 40.06
- Support Level
- PHIO $2.03
- FTEL $0.44
- Resistance Level
- PHIO $2.29
- FTEL $0.56
- Average True Range (ATR)
- PHIO 0.16
- FTEL 0.07
- MACD
- PHIO -0.03
- FTEL -0.02
- Stochastic Oscillator
- PHIO 22.39
- FTEL 11.21
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.